Followers | 818 |
Posts | 31359 |
Boards Moderated | 6 |
Alias Born | 03/22/2016 |
Tuesday, January 09, 2024 10:13:57 AM
Recent NGM News
- NGM Bio Announces Closing of Tender Offer • GlobeNewswire Inc. • 04/05/2024 01:19:51 PM
- NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting • GlobeNewswire Inc. • 03/19/2024 09:30:44 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/11/2024 08:15:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:13:03 PM
- NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/11/2024 08:05:00 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 03/08/2024 10:32:53 PM
- Form SC 14D9 - Solicitation, recommendation statements • Edgar (US Regulatory) • 03/08/2024 10:21:26 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 02/26/2024 10:11:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 10:01:00 PM
- NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP • GlobeNewswire Inc. • 02/26/2024 02:03:59 PM
- NGM Bio to Participate in the Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/20/2024 09:01:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 11:12:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 11:09:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 11:03:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 11:02:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 11:01:27 PM
- NGM Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference • GlobeNewswire Inc. • 01/17/2024 09:47:32 PM
- NGM Bio Announces New Clinical Data from Ongoing Trial of NGM707 in Advanced Solid Tumors and Outlines Evolved Strategy for Aldafermin and NGM120 to Focus on Rare Conditions with Significant Unmet Need • GlobeNewswire Inc. • 01/09/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 12:30:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 10:19:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2023 09:27:06 PM
- NGM Bio Presents Positive Phase 2b Results from the ALPINE 4 Trial of Aldafermin in Patients with Compensated Cirrhosis (F4) Due to NASH at AASLD The Liver Meeting® • GlobeNewswire Inc. • 11/13/2023 02:45:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/08/2023 11:13:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/08/2023 11:11:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/08/2023 11:09:09 PM
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM